NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review

Date: March 12, 2013
Pages: 39
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: N39BD10C489EN
Leaflet:

Download PDF Leaflet

Summary

NeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutical agents for the treatment of various life threatening diseases. It mainly focuses on finding treatment indications for central nervous system (CNS) disorders such as Huntington’s, Parkinson’s and Alzheimer’s diseases, pain, epilepsy and psychiatric disorders such as depression, anxiety, attention deficit hyperactivity disorder (ADHD) and schizophrenia. Its product pipeline comprises ordopidine and seridopidine, both have completed phase I studies, as well as tesofensine, which have completed phase II and NS2359 which has completed phase I.

NeuroSearch AS Key Recent Developments

Jun 27, 2012: NeuroSearch Announces Senior Management ChangesnGDPH62301FSA

This comprehensive SWOT profile of NeuroSearch AS provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY

NeuroSearch A/S - Key Facts
NeuroSearch A/S - Key Employees
NeuroSearch A/S - Key Employee Biographies
NeuroSearch A/S - Major Products and Services
NeuroSearch A/S - Pharmaceutical Pipeline Products Data
NeuroSearch A/S, Pipeline Products by Therapy Area
NeuroSearch A/S, Pipeline Products by Development Phase
NeuroSearch A/S - History
NeuroSearch A/S - Company Statement
NeuroSearch A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate

SECTION 2 – COMPANY ANALYSIS

NeuroSearch A/S - Business Description
NeuroSearch A/S - Corporate Strategy
NeuroSearch A/S - SWOT Analysis
SWOT Analysis - Overview
NeuroSearch A/S - Strengths
Strength - Broad Product Pipeline
Strength - Strategic Partnerships
Strength - Drug Discovery Platforms
NeuroSearch A/S - Weaknesses
Weakness - History of Losses
Weakness - Drug Candidate Asset Sale
Weakness - Declining Returns
NeuroSearch A/S - Opportunities
Opportunity - Focus on Major Therapeutic Areas
Opportunity - Changing Demographics
NeuroSearch A/S - Threats
Threat - Emergence of Biogenerics / Biosimilars
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
NeuroSearch A/S - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
NeuroSearch A/S, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

NeuroSearch A/S, Recent Developments
Jun 27, 2012: NeuroSearch Announces Senior Management Changes

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NeuroSearch A/S, Key Facts
NeuroSearch A/S, Key Employees
NeuroSearch A/S, Key Employee Biographies
NeuroSearch A/S, Major Products and Services
NeuroSearch A/S, Number of Pipeline Products by Therapy Area
NeuroSearch A/S, Number of Pipeline Products by Development Stage
NeuroSearch A/S, Pipeline Products By Therapy Area and Development Phase
NeuroSearch A/S, History
NeuroSearch A/S, Subsidiaries
NeuroSearch A/S, Affiliate
NeuroSearch A/S, Key Competitors
NeuroSearch A/S, Ratios based on current share price
NeuroSearch A/S, Annual Ratios
NeuroSearch A/S, Interim Ratios
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
NeuroSearch A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

NeuroSearch A/S, Pipeline Products by Therapy Area
NeuroSearch A/S, Pipeline Products by Development Phase
NeuroSearch A/S, Performance Chart (2008 - 2012)
NeuroSearch A/S, Ratio Charts
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Ask Your Question

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: